Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inventiva SA (GB:0RNK)
:0RNK
Holding GB:0RNK?
Track your performance easily
0RNK Stock Chart & Stats
Day’s Range― - ―
52-Week Range€1.46 - €3.80
Previous CloseN/A
Volume2.44K
Average Volume (3M)154.00
Market Cap
€202.91M
Enterprise Value€187.19M
Total Cash (Recent Filing)$22.60M
Total Debt (Recent Filing)$503.99K
Price to Earnings (P/E)―
Beta0.97
Next Earnings
Mar 26, 2025EPS Estimate
-0.58Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.06
Shares Outstanding95,662,390
10 Day Avg. Volume69
30 Day Avg. Volume154
Standard Deviation0.25
R-Squared0.04
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)8.49
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.92
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.08
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0RNK FAQ
What was Inventiva SA’s price range in the past 12 months?
Inventiva SA lowest share price was €1.46 and its highest was €3.80 in the past 12 months.
What is Inventiva SA’s market cap?
Inventiva SA’s market cap is €202.91M.
When is Inventiva SA’s upcoming earnings report date?
Inventiva SA’s upcoming earnings report date is Mar 26, 2025 which is in 65 days.
How were Inventiva SA’s earnings last quarter?
Inventiva SA released its earnings results on Sep 25, 2024. The company reported -€0.808 earnings per share for the quarter, missing the consensus estimate of -€0.721 by -€0.087.
Is Inventiva SA overvalued?
According to Wall Street analysts Inventiva SA’s price is currently Overvalued.
Does Inventiva SA pay dividends?
Inventiva SA does not currently pay dividends.
What is Inventiva SA’s EPS estimate?
Inventiva SA’s EPS estimate is -0.58.
How many shares outstanding does Inventiva SA have?
Inventiva SA has 95,662,390 shares outstanding.
What happened to Inventiva SA’s price movement after its last earnings report?
Inventiva SA reported an EPS of -€0.808 in its last earnings report, missing expectations of -€0.721. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Inventiva SA?
Currently, no hedge funds are holding shares in GB:0RNK
---
Company Description
Inventiva SA
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis and rare diseases. All the company's operations are located in France.
---
Technical Analysis
---